Procalcitonin and Interleukin-6 as Prognostic Markers in Intensive Care Unit Patients with Covid-19 in Minia University Hospital

Value of Interleukin 6 in Assessment of the Disease Severity in Patients with COVID-19 Infection without Preexisting Comorbidities

Inflammatory Biomarkers as Prognostic and Predictive Factor in Patients with COVID-19

Diagnostic Value of Serum Level of Interleukin 33 (IL-33), C-C Motif Chemokine Ligand 17 (CCL17) and Interferon Gamma Inducible Protein-10 (IP-10) in Coronavirus Disease 2019 (CO

The Clinical Utility of Serial Procalcitonin and Procalcitonin Clearance in Predicting the ‎Outcome of COVID-19 Egyptian Patients

The Role of Procalcitonin and Serum Amyloid a As a Laboratory Biomarker in COVID-19

Role of measuring serum procalcitonin and receiving prophylactic antibiotic therapy in critical COVID-19 patients.

Evaluation of the predictive value of C-reactive protein, interleukin-6 and their derived immune-inflammatory indices in COVID-19 Egyptian patients

Neutrophil- and platelet-lymphocyte ratios as valuable prognostic biomarkers in ICU COVID-19 patients

Combining Serum Interleukin-6 and other Inflammatory Biomarkers to Improve the Prediction of COVID-19 Severity